logo


You're contacting media contact of this press release

Title: CoreAge Rx is the Best Telehealth GLP-1 Program for Weight Management: Health Ful Plus Latest Review Recognizes Platform as No. 1 in 2026

United States, 3rd Mar 2026 - CoreAge Rx, a nationwide telehealth platform specializing in GLP-1–based treatment programs for weight management, has been recognized as the top-ranked provider in a newly released independent review by Healthful Plus. The evaluation places CoreAge Rx at the forefront of telehealth GLP-1 services for 2026, citing its medical oversight, personalized treatment protocols, and comprehensive patient support.As demand for medically supervised GLP-1 programs continues to rise, individuals increasingly seek structured, physician-guided solutions that prioritize safety, personalization, and long-term health outcomes. CoreAge Rx has positioned itself as a leading option in this category by offering access to GLP-1 medications through a fully remote model designed to streamline care while maintaining high medical standards.CoreAge Rx provides access to semaglutide and tirzepatide as part of its comprehensive GLP-1 programs for weight management. Treatment plans are developed and overseen by board-certified physicians who evaluate each patient’s health profile before recommending therapy. The company emphasizes individualized care, ensuring that treatment protocols align with each patient’s medical history, goals, and ongoing progress.Through its telehealth infrastructure, CoreAge Rx enables patients to complete consultations, receive prescriptions when appropriate, and maintain ongoing communication with licensed medical professionals without the need for in-person clinic visits. This model supports accessibility and continuity of care, particularly for busy adults seeking structured weight management programs under physician supervision.A key component of the CoreAge Rx program is ongoing medical monitoring. Patients receive continued guidance and f...


This press release is issued by King Newswire

Email Information